Expression of Inflammatory Proteins in Pancreatic Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00551057

Enrollment

150

Registered

2007-10-30

Start date

2007-10-31

Completion date

2012-10-31

Last updated

2010-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Neoplasms

Brief summary

The purpose of this trial is to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue.

Detailed description

Purpose: to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue * Trial with surgical intervention

Interventions

BEHAVIORALExpression type

to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with pancreatic cancer or chronic pancreatitis

Exclusion criteria

* Patients with alpha 1-antitrypsin deficiency

Countries

Switzerland

Contacts

Primary ContactMarc Schiesser, MD

marc.schiesser@usz.ch+41 (0)44 255 11 11

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026